Exhibit 1.1
EXECUTION VERSION
LEXINGTON REALTY TRUST
10,000,000 Shares of Beneficial Interest
Classified as Common Stock
UNDERWRITING AGREEMENT
Dated: September 4, 2019
LEXINGTON REALTY TRUST
10,000,000 Shares of Beneficial Interest
Classified as Common Stock
UNDERWRITING AGREEMENT
September 4, 2019
J.P. Morgan Securities LLC
383 Madison Avenue, 5th Floor
New York, New York 10179
Wells Fargo Securities, LLC
375 Park Avenue
New York, New York 10152
Ladies and Gentlemen:
THIS UNDERWRITING AGREEMENT
(this “Agreement”) is made as of September 4, 2019, by and between Lexington Realty Trust, a Maryland real estate
investment trust (the “Company”), J.P. Morgan Securities LLC and Wells Fargo Securities, LLC (collectively,
the “Underwriters”) with respect to (i) the issue and sale of a total of 10,000,000 shares of beneficial interest
of the Company (the “Initial Securities”) classified as common stock, par value $0.0001 per share (the “Common
Shares”), and the purchase by the Underwriters, acting severally and not jointly, of the respective number of Initial
Securities set forth opposite the names of the Underwriters listed on Schedule I hereto, and (ii) the grant by the Company
of the option described in Section 3(b) hereof to the Underwriters, acting severally and not jointly, in amounts proportionate
to the respective numbers of Initial Securities set forth opposite the names of the Underwriters listed on Schedule I hereto.
The Initial Securities to be purchased by the Underwriters and all or any part of the 1,500,000 additional Common Shares subject
to the option described in Section 3(b) hereof (the “Option Securities”) are hereinafter called, collectively,
the “Securities.”
The Company understands
that the Underwriters propose to make a public offering of the Securities pursuant to the terms of this Agreement.
Section
1. Description of Securities.
The Company has prepared
and filed with the Securities and Exchange Commission (the “Commission”), in accordance with the provisions
of the Securities Act of 1933, as amended, and the rules and regulations thereunder (collectively, the “Securities Act”),
an automatic shelf registration statement on Form S-3ASR (File No. 333-223257), which became effective upon filing, covering the
registration of the Securities and certain other securities of the Company. Promptly after execution and delivery of this Agreement,
the Company will prepare and file a prospectus supplement in accordance with the provisions of Rule 430B (“Rule 430B”)
of the Securities Act and paragraph (b) of Rule 424 (“Rule 424(b)”) of the Securities Act. Any information included
in a prospectus and such related prospectus supplement that was omitted from such registration statement at the time it became
effective but that is deemed to be part of and included in such registration statement pursuant to Rule 430B is referred to as
“Rule 430B Information.” Each prospectus and prospectus supplement used in connection with the offering of the Securities
that omitted Rule 430B Information is herein called a “preliminary prospectus.” Such registration statement, at any
given time, together with the amendments thereto to such time, the exhibits and any schedules thereto at such time, the documents
incorporated by reference therein pursuant to Item 12 of Form S-3 under the Securities Act at such time, the documents otherwise
deemed to be a part thereof or included therein by the Securities Act at such time and the Rule 430B Information, are herein called,
collectively, the “Registration Statement.” Any registration statement filed pursuant to Rule 462(b) of the Securities
Act is herein referred to as the “ Rule 462(b) Registration Statement,” and after such filing the term “Registration
Statement” shall include the Rule 462(b) Registration Statement. The final prospectus in the form first furnished (electronically
or otherwise) to the Underwriters for use in connection with the offering of the Securities (whether to meet the requests of purchasers
pursuant to Rule 173 under the Securities Act or otherwise) or, if not furnished to the Underwriters, in the form first filed by
the Company pursuant to Rule 424(b), together with the documents incorporated by reference therein pursuant to Item 12 of Form
S-3 under the Securities Act at the time of execution of this Agreement and any preliminary prospectuses that form a part thereof
is herein called the “Prospectus.” For purposes of this Agreement, all references to the Registration Statement, any
preliminary prospectus, the Prospectus or any amendment or supplement to any of the foregoing shall be deemed to include the copy
filed with the Commission pursuant to its Electronic Data Gathering, Analysis and Retrieval system (“EDGAR”),
as supplemented by its Interactive Data Electronic Applications system.
All references in this
Agreement to financial statements and schedules and other information which is “contained,” “included”
or “stated” in the Registration Statement, any preliminary prospectus or the Prospectus (or other references of like
import) shall be deemed to mean and include all such financial statements and schedules and other information which is incorporated
by reference in or otherwise deemed by the Securities Act to be a part of or included in the Registration Statement, any preliminary
prospectus or the Prospectus, as the case may be; and all references in this Agreement to amendments or supplements to the Registration
Statement, any preliminary prospectus or the Prospectus shall be deemed to mean and include the filing of any document under the
Securities Exchange Act of 1934, as amended (the “Exchange Act”), which is incorporated by reference in or otherwise
deemed by the Securities Act to be a part of or included in the Registration Statement, any preliminary prospectus or the Prospectus,
as the case may be, as of the time at which such representation, warranty or agreement is made.
Section
2. Representations and Warranties.
(a)
Representations and Warranties by the Company. The Company hereby represents and
warrants to the Underwriters as of the date hereof, as of the Initial Sale Time (as defined below), as of the Closing Date referred
to in Section 3(c) hereof and as of each Option Closing Date (if any) referred to in Section 3(b) hereof, and agrees
with the Underwriters, as follows:
(1)
The Company meets the requirements for use of Form S-3 under the Securities Act. The Registration
Statement and any post-effective amendments thereto have become effective under the Securities Act. No stop order suspending the
effectiveness of the Registration Statement has been issued under the Securities Act and no proceedings for that purpose have been
instituted or are pending or, to the knowledge of the Company, are contemplated by the Commission, and any request on the part
of the Commission for additional information has been complied with.
(2)
At the respective times the Registration Statement and any post-effective amendments thereto
became or become effective, at each deemed effective date of the Registration Statement with respect to the Underwriters pursuant
to Rule 430B(f)(2) of the Securities Act and at the Closing Date (and, if any Option Securities are purchased, at the applicable
Option Closing Date), the Registration Statement complied and will comply in all material respects with the requirements of the
Securities Act and did not and will not contain an untrue statement of a material fact or omit to state a material fact required
to be stated therein or necessary to make the statements therein not misleading.
(3)
The Prospectus and any amendments or supplements thereto, at the time the Prospectus or
any such amendment or supplement was issued and at the Closing Date (and, if any Option Securities are purchased, at the applicable
Option Closing Date), complied and will comply in all material respects with the requirements of the Securities Act and did not
and will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading.
(4)
Each preliminary prospectus (including any prospectus or prospectuses filed as part of the
Registration Statement at the time it originally became effective or any amendment thereto), complied when so filed in all material
respects with the Securities Act and each preliminary prospectus and the Prospectus delivered to the Underwriters for use in connection
with the offering of the Securities was identical to the electronically transmitted copies thereof filed with the Commission pursuant
to EDGAR, except to the extent permitted by Regulation S-T.
(5)
As of the Initial Sale Time, neither (x) the Issuer General Use Free Writing Prospectus(es)
(as defined below) issued at or prior to the Initial Sale Time (as defined below), each preliminary prospectus issued at or prior
to the Initial Sale Time and the information included on Schedule III hereto all considered together (collectively, the
“ Disclosure Package”), nor (y) any individual Issuer Limited Use Free Writing Prospectus (as defined below),
when considered together with the Disclosure Package, included any untrue statement of a material fact or omitted to state any
material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading.
As used in this
subsection and elsewhere in this Agreement:
“Initial
Sale Time” means 6:00 p.m. (Eastern time) on September 4, 2019 or such other time as agreed by the Company and the Underwriters.
“Issuer
Free Writing Prospectus” means any “issuer free writing prospectus,” as defined in Rule 433 of the Securities
Act (“Rule 433”), relating to the Securities that (i) is required to be filed with the Commission by the Company,
(ii) is a “road show that is a written communication” within the meaning of Rule 433(d)(8)(i), whether or not required
to be filed with the Commission, or (iii) is exempt from filing pursuant to Rule 433(d)(5)(i) because it contains a description
of the Securities or of the offering that does not reflect the final terms, in each case in the form filed or required to be filed
with the Commission or, if not required to be filed, in the form retained in the Company’s records pursuant to Rule 433(g).
“Issuer
General Use Free Writing Prospectus” means any Issuer Free Writing Prospectus that is intended for general distribution
to prospective investors (other than a “road show” (as defined in Rule 433(h)) that is not required to be filed with
the Commission pursuant to Rule 433(d)(8)(i)), as evidenced by its being specified in Schedule II hereto.
“Issuer
Limited Use Free Writing Prospectus” means any Issuer Free Writing Prospectus that is not an Issuer General Use Free
Writing Prospectus.
(6)
Each Issuer Free Writing Prospectus relating to the Securities, as of its issue date and
at all subsequent times through the completion of the public offer and sale of the Securities or until any earlier date that the
Company notified or notifies the Underwriters as described in Section 4(e) hereof, did not, does not and will not include
any information that conflicted, conflicts or will conflict with the information contained in the Registration Statement or the
Prospectus, including any incorporated document any preliminary or other prospectus deemed to be a part thereof that has not been
superseded or modified, or did not, does not and will not include or, when considered together with the Registration Statement,
the Disclosure Package and the Prospectus and all amendments and supplement thereto, and all other Issuer Free Writing Prospectuses
and all amendments and supplements thereto, will include an untrue statement of a material fact or did not, does not or will not
omit to state a material fact necessary in order to make the statements therein, in light of the circumstances, prevailing at such
time, not misleading.
(7)
The representations and warranties in subsections 1 through 6 of this Section 2 shall
not apply to statements in or omissions from the Registration Statement, the Prospectus or any Issuer Free Writing Prospectus made
in reliance upon and in conformity with written information furnished to the Company by or on behalf of any of the Underwriters
expressly for use therein (the “Underwriters’ Information”). The parties acknowledge and agree that the
Underwriters’ Information consists solely of the following information: (i) the names of the Underwriters on the cover page
and the back cover page of the Prospectus; (ii) the last sentence of the fourth paragraph under “Underwriting”
on p. S-8; (iii) the fifth paragraph on page S-8; and (iv) the first paragraph, the second paragraph and the third paragraph
under the subheading “Price Stabilization, Short Positions” under “Underwriting” on page S-9.
(8)
The documents incorporated or deemed to be incorporated by reference in the Registration
Statement, the Disclosure Package and the Prospectus, when they became effective or at the time they were or hereafter are filed
with the Commission, as of such date, complied and will comply in all material respects with the requirements of the Exchange Act,
as applicable, and, when read together with the other information in the Prospectus, the Registration Statement, the Disclosure
Package or the Prospectus, as the case may be, did not and will not contain an untrue statement of a material fact or omit to state
a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under
which they were made, not misleading.
(9)
At the time of filing of the Registration Statement and any post-effective amendments thereto,
at the earliest time thereafter that the Company or another offering participant made a bona fide offer (within the meaning of
Rule 164(h)(2) of the Securities Act) of the Securities and at the date hereof, the Company was not and is not an “ineligible
issuer,” as defined in Rule 405 of the Securities Act.
(10)
The descriptions in the Registration Statement, the Disclosure Package and the Prospectus
of the contracts, leases and other legal documents therein described present fairly the information required to be shown, and there
are no contracts, leases, or other documents of a character required to be described in the Registration Statement, the Disclosure
Package or the Prospectus or to be filed as exhibits to the Registration Statement, which are not described or filed as required;
there are no legal or governmental proceedings pending or, to the knowledge of the Company, threatened, to which the Company or
any Subsidiary (as defined below) is subject that are required to be described in the Registration Statement, the Disclosure Package
or the Prospectus and are not so described; there are no statutes or regulations applicable to the Company or any Subsidiary or
certificates, permits or other authorizations from governmental regulatory officials or bodies required to be obtained or maintained
by the Company or any Subsidiary of a character required to be disclosed that are not so described therein as required; all agreements
between the Company or any Subsidiary and third parties expressly referenced in the Registration Statement, the Disclosure Package
and the Prospectus are legal, valid and binding obligations of the Company or the Subsidiary, enforceable in accordance with their
respective terms, except to the extent enforceability may be limited by bankruptcy, insolvency, reorganization or other laws of
general applicability relating to or affecting creditors’ rights and by general equity principles; there are no business
relationships or related-party transactions involving the Company or any Subsidiary required to be described in the Registration
Statement, the Disclosure Package and the Prospectus which have not been so described as required.
(11)
Deloitte & Touche LLP, who audited the financial statements and supporting schedules
of the Company and its Subsidiaries for its fiscal years ended December 31, 2018 and 2017, which are included or incorporated by
reference in the Registration Statement, the Disclosure Package and the Prospectus, is an independent registered public accounting
firm with respect to the Company as required by the Securities Act, the Exchange Act and the Public Company Accounting Oversight
Board (“PCAOB”). KPMG LLP, who audited the financial statements and supporting schedules of the Company and
its Subsidiaries for its fiscal year ended December 31, 2016, which are included or incorporated by reference in the Registration
Statement and the Prospectus, was an independent registered public accounting firm at the date of such audit report with respect
to the Company as required by the Securities Act, the Exchange Act and the PCAOB.
(12)
The financial statements of the Company and its Subsidiaries (collectively, the “Company
Financial Statements”), included or incorporated by reference in the Registration Statement, the Disclosure Package and
the Prospectus, and any financial statements required by Rule 3-14 of Regulation S-X (the “Acquisition Financial Statements”),
which are incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus, present fairly the
financial position of the Company and its consolidated Subsidiaries at the dates indicated, or, if applicable, with respect to
the Acquisition Financial Statements, the respective property or tenant; and all such financial statements have been prepared in
conformity with United States generally accepted accounting principles (“GAAP”) applied on a consistent basis
throughout the periods involved and comply with all applicable accounting requirements under the Securities Act and the Exchange
Act, except as disclosed therein and that unaudited financial statements may not contain all footnotes required by GAAP and subject,
in the case of unaudited financial statements, to normal year-end audit adjustments. The supporting schedules, if any, included
or incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus present fairly, in accordance
with GAAP, the information required to be stated therein. There are no financial statements or schedules required to be included
or incorporated by reference in the Registration Statement, the Disclosure Package or the Prospectus under the Securities Act,
which are not so included or incorporated. If applicable, the unaudited pro forma financial information (including the related
notes) included or incorporated by reference in the Registration Statement, the Disclosure Package or the Prospectus complies as
to form in all material respects with the applicable accounting requirements of the Securities Act, and management of the Company
believes that the assumptions underlying the pro forma adjustments are reasonable. If applicable, such pro forma adjustments have
been properly applied to the historical amounts in the compilation of the information and such information fairly presents with
respect to the Company and its consolidated Subsidiaries, the financial position, results of operations and other information purported
to be shown therein at the respective dates and for the respective periods specified. No pro forma financial information is required
to be included or incorporated by reference in the Registration Statement, the Disclosure Package or the Prospectus which is not
so included or incorporated. Any non-GAAP financial measures, as defined under Regulation G of the Exchange Act (“Regulation
G”), included or incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus are
permitted for use in documents filed with the Commission and comply with Regulation G and Item 10 of Regulation S-K of the Securities
Act, to the extent applicable. The ratio of earnings to fixed charges, if any, contained in the Registration Statement, the Disclosure
Package and the Prospectus has been calculated in accordance with Item 503(d) of Regulation S-K. The interactive data in eXtensible
Business Reporting Language incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus
fairly presents the information called for in all material respects and has been prepared in accordance with the Commission’s
rules and guidelines applicable thereto.
(13)
Since the respective dates as of which information is given in the Registration Statement,
the Disclosure Package or the Prospectus, except as otherwise stated therein, (A) there has been no material adverse change, nor
any development or event involving a prospective material adverse change, in the condition, financial or otherwise, or in the earnings,
investment portfolio, business affairs or business prospects of the Company and the Subsidiaries considered as one enterprise,
whether or not arising in the ordinary course of business (a “Material Adverse Effect”), (B) there have been
no transactions entered into by any of the Company or the Subsidiaries, which are material with respect to the Company and the
Subsidiaries, considered as one enterprise, and (C) except as disclosed in the Company’s press releases, there has been no
dividend or distribution of any kind declared, paid or made by the Company on any class of its shares of beneficial interest.
(14)
The Company has been duly organized and is an existing statutory real estate investment
trust in good standing under the laws of the State of Maryland, with power and authority (trust or other) to own and operate its
properties and conduct its business as described in the Registration Statement, the Disclosure Package and the Prospectus. Except
where the failure to so qualify or to be in good standing would not result in a Material Adverse Effect, the Company is duly qualified
to do business as a foreign entity in good standing in all other jurisdictions in which its ownership or lease of property or the
conduct of its business requires such qualification.
(15)
Exhibit 21 of the Company’s most recent Annual Report on Form 10-K, attached hereto
as Exhibit B (which may be modified from time to time by the Company upon notice to the Underwriters in writing on or prior
to the date hereof), is a true, correct and complete list, as of the date hereof, of all of the subsidiaries of the Company controlled
directly or indirectly by the Company (each, a “Subsidiary” and collectively, the “Subsidiaries”),
including the jurisdiction of incorporation or organization of each such Subsidiary and including each Subsidiary that is a “significant
subsidiary” as defined by Rule 1-02 of Regulation S-X. For the avoidance of doubt, the term “Subsidiary” as used
in this Agreement and the Exhibits hereto includes, without limitation, LCIF.
(16)
Each Subsidiary has been duly incorporated or formed, as the case may be, and each is existing
and in good standing under the laws of its respective jurisdiction of incorporation or formation, with power and authority (corporate,
partnership, trust or other) to own or lease its properties and conduct its business as described in the Registration Statement,
the Disclosure Package and the Prospectus. Except where the failure to so qualify or to be in good standing would not result in
a Material Adverse Effect, each Subsidiary is duly qualified to do business as a foreign entity in good standing in all other jurisdictions
in which its ownership or lease of property or the conduct of its business requires such qualification. All of the issued and outstanding
equity interests of each Subsidiary have been duly authorized and validly issued and are fully paid and non-assessable; and the
equity interests of each Subsidiary owned by the Company or another Subsidiary, directly or through subsidiaries, are owned free
from security interests, liens, claims, encumbrances and defects, except (i) as disclosed in the Registration Statement, the Disclosure
Package and the Prospectus or (ii) where such security interests, liens, claims, encumbrances and defects would not have a Material
Adverse Effect. Immediately prior to the consummation of the transactions contemplated hereby and the application of the net proceeds
received by the Company from the sale of the Securities, the Company owns the sole general partnership interest and a majority
of the limited partnership interests in Lepercq Corporate Income Fund L.P., a Delaware limited partnership (“LCIF”).
(17)
The Company’s authorized, issued and outstanding shares of beneficial interest of
the Company as of June 30, 2019 are as set forth in the Company’s Quarterly Report on Form 10-Q for the quarterly period
ended June 30, 2019 (No. 001-12386), filed with the Commission on August 7, 2019. As of September 1, 2019, 237,761,593 Common Shares
were issued and outstanding. This Agreement and the issuance and sale of the Securities hereunder has been duly authorized by all
appropriate action of the Company, all outstanding shares of beneficial interest of the Company are, and, when the Securities have
been delivered and paid for in accordance with this Agreement on the Closing Date and each Option Closing Date, if any, such Securities
will be, validly issued, fully paid and non-assessable and will conform to the description thereof contained or incorporated by
reference in the Disclosure Package and the Prospectus; except as provided in the Company’s Amended and Restated Dividend
Reinvestment and Direct Shares Purchase plan or as described in the Disclosure Package and the Prospectus, there is no outstanding
option, warrant or other right calling for the issuance of, and no commitment, plan or arrangement to issue, any shares of beneficial
interest of the Company or any security convertible into or exchangeable for shares of beneficial interest of the Company, and
the shareholders of the Company have no preemptive or similar rights with respect to any shares of beneficial interest of the Company.
(18)
Except as described in the Registration Statement, the Disclosure Package and the Prospectus
or as provided herein, there are no contracts, agreements or understandings between the Company or the Subsidiaries and any person
that would give rise to a valid claim against the Company or any of the Underwriters for a brokerage commission, finder’s
fee or other like payment in connection with the offering, issuance and sale of the Securities.
(19)
Except as described in the Registration Statement, the Disclosure Package and the Prospectus,
there are no contracts, agreements or understandings between the Company or the Subsidiaries and any person granting such person
the right to require the Company to file a registration statement under the Securities Act with respect to any securities of the
Company owned or to be owned by such person or to require the Company to include such securities in the securities registered pursuant
to the Registration Statement or in any securities being registered pursuant to any other registration statement filed by the Company
under the Securities Act.
(20)
The Securities will be approved for listing on the New York Stock Exchange (the “NYSE”)
on or prior to the first Closing Date, subject to final notice of issuance.
(21)
No consent, approval, license, authorization, certificate, permit or order of, or filing
with, any governmental agency or body or any court is required for the consummation of the transactions contemplated by this Agreement
including the valid authorization, issuance, sale and delivery of the Securities, except such as may be required under the Securities
Act, the Exchange Act, the rules of the NYSE and state securities laws.
(22)
The execution, delivery and performance of this Agreement and the issuance and sale of the
Securities will not result in a breach or violation of any of the terms and provisions of, or constitute a default under, any statute,
rule, regulation or order of any governmental agency or body or any court, domestic or foreign, having jurisdiction over the Company
or the Subsidiaries or any of their Properties (as defined below), or any agreement or instrument to which the Company or any Subsidiary
is a party or by which the Company or any Subsidiary is bound or to which any of the Properties, as defined below, of the Company
or any Subsidiary is subject, or the charter, by-laws, partnership agreement, certificate of limited partnership, operating agreement
or other organizational documents of the Company or any Subsidiary, and the Company has full power and authority to authorize,
issue, sell and deliver the Securities as contemplated by this Agreement.
(23)
This Agreement has been duly authorized, executed and delivered by the Company and constitutes
the legal, valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except as
the enforcement thereof may be limited by bankruptcy, insolvency (including, without limitation, all laws relating to fraudulent
transfers), reorganization, moratorium or similar laws affecting enforcement of creditors’ rights generally and except as
enforcement thereof is subject to general principles of equity (regardless of whether enforcement is considered in a proceeding
in equity or at law).
(24)
Except as described in the Registration Statement, the Disclosure Package and the Prospectus,
the Company, its Subsidiaries, and the joint ventures in which the Company and its Subsidiaries have an ownership interest, have
good and marketable title to all real properties and all other properties and assets owned by them (each, a “Property”
and collectively, the “Properties”), in each case free from liens, encumbrances and defects, except where the
existence of any lien, encumbrance or defect would not have a Material Adverse Effect; the Company or the applicable Subsidiary
has obtained an owner’s title insurance policy in an amount at least equal to the cost of acquisition from a title insurance
company with respect to each of its real estate properties, except where the failure to obtain such owner’s title insurance
policy would not have a Material Adverse Effect; except as disclosed in the Registration Statement, the Disclosure Package and
the Prospectus, the Company and the Subsidiaries hold any leased real or personal property leased by them under valid and enforceable
leases, except where the invalidity or unenforceability of such leases, individually or collectively, would not have a Material
Adverse Effect; no person has an option or right of first refusal to purchase all or part of any Property or any interest therein
for other than the fair market value, except where the exercise of such option or right would not have a Material Adverse Effect;
neither the Company nor any Subsidiary has knowledge of any pending or threatened condemnation proceeding, zoning change, or other
proceeding or action that will in any material manner affect the size of, use of, improvements on, construction on or access to
any of the Properties.
(25)
The Company and the Subsidiaries possess adequate permits, licenses, franchises, certificates,
authorities, consents, orders or approvals issued by appropriate governmental agencies or bodies necessary to conduct the business
now conducted by them or contemplated by the Registration Statement, the Disclosure Package and the Prospectus and have not received
any notice of proceedings relating to the revocation or modification of any such permits, licenses, franchises, certificates, authorities,
consents, orders or approvals that, if determined adversely to the Company or any Subsidiary, would, individually or in the aggregate,
have a Material Adverse Effect.
(26)
No labor dispute with the employees of the Company or any Subsidiary exists or, to the knowledge
of the Company, is imminent that might have a Material Adverse Effect.
(27)
The Company and the Subsidiaries own, or have obtained valid and enforceable licenses for,
the material inventions, patent applications, patents, trademarks, trade names, service names, copyrights, trade secrets and other
intellectual property as being owned or licensed by them and which are necessary for the conduct of their respective businesses
as currently conducted (collectively, “Intellectual Property”), and the conduct of their respective businesses
does not and will not infringe, misappropriate or otherwise conflict in any material respect with any such rights of others. The
Intellectual Property has not been adjudged by a court of competent jurisdiction to be invalid or unenforceable, in whole or in
part, and the Company is unaware of any facts which would form a reasonable basis for any such adjudication. To the Company’s
knowledge: (i) there are no third parties who have rights to any Intellectual Property, except for customary reversionary rights
of third-party licensors with respect to Intellectual Property as licensed to the Company or the Subsidiaries; and (ii) there is
no infringement by third parties of any Intellectual Property. Except as would not be reasonably likely to have a Material Adverse
Effect, there is no pending or, to the Company’s knowledge, threatened action, suit, proceeding or claim by others: (A) challenging
the Company’s or any Subsidiary’s rights in or to any Intellectual Property, and the Company is unaware of any facts
which would form a reasonable basis for any such action, suit, proceeding or claim; (B) challenging the validity, enforceability
or scope of any Intellectual Property, and the Company is unaware of any facts which would form a reasonable basis for any such
action, suit, proceeding or claim; or (C) asserting that the Company or any Subsidiary infringes or otherwise violates, any patent,
trademark, trade name, service name, copyright, trade secret or other proprietary rights of others, and the Company is unaware
of any facts which would form a reasonable basis for any such action, suit, proceeding or claim. The Company and the Subsidiaries
have complied in all material respects with the terms of each agreement pursuant to which Intellectual Property has been licensed
to the Company or any Subsidiary, and all such agreements are in full force and effect. To the Company’s knowledge, there
are no material defects in any of the patents or patent applications included in the Intellectual Property. The Company and the
Subsidiaries have taken all reasonable steps to protect, maintain and safeguard their Intellectual Property, including the execution
of appropriate nondisclosure, confidentiality agreements and invention assignment agreements and invention assignments with their
employees, and, to the Company’s knowledge, no employee of the Company or any Subsidiary is in or has been in violation of
any term of any employment contract, patent disclosure agreement, invention assignment agreement, non-competition agreement, non-solicitation
agreement, nondisclosure agreement, or any restrictive covenant to or with a former employer where the basis of such violation
relates to such employee’s employment with the Company or such Subsidiary, as applicable. None of the Intellectual Property
or material technology (including information technology and outsourced arrangements) owned or employed by the Company or the Subsidiaries
has been obtained or is being used by the Company or the Subsidiaries in violation of any material contractual obligation binding
on the Company or the relevant Subsidiary or, to the knowledge of the Company, otherwise in material violation of the rights of
any persons.
(28)
Except as (x) otherwise described in the Registration Statement, the Disclosure Package
and the Prospectus or (y) could not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect,
neither the Company nor any Subsidiary has authorized or conducted or has knowledge of the generation, transportation, storage,
presence, use, treatment, disposal, release, or other handling of any hazardous substance, hazardous waste, hazardous material,
hazardous constituent, toxic substance, pollutant, contaminant, asbestos, radon, polychlorinated biphenyls, petroleum product or
waste (including crude oil or any fraction thereof, natural gas, liquefied gas, synthetic gas or other material defined, regulated,
controlled or potentially subject to any remediation requirement under any environmental law (collectively, “Hazardous
Materials”), on, in, under or affecting any Property, except in material compliance with applicable laws; except as disclosed
in the Registration Statement, the Disclosure Package and the Prospectus, to the knowledge of the Company, the Properties are in
compliance with all federal, state and local laws, ordinances, rules, regulations and other governmental requirements relating
to pollution, control of chemicals, management of waste (collectively, “Environmental Laws”), and the Company
and the Subsidiaries are in compliance with all licenses, permits, registrations and government authorizations necessary to operate
under all applicable Environmental Laws in all material respects; except as otherwise described in the Registration Statement,
the Disclosure Package and the Prospectus, neither the Company nor any Subsidiary has received any written or oral notice from
any governmental entity or any other person and there is no pending, or, to the knowledge of the Company, threatened claim, litigation
or any administrative agency proceeding that: alleges a violation of any Environmental Laws by the Company or any Subsidiary; or
that the Company or any Subsidiary is a liable party or a potentially responsible party under the Comprehensive Environmental Response,
Compensation and Liability Act, 42 U.S.C. § 9601, et seq., or any state superfund law; has resulted in or could result in
the attachment of an environmental lien on any of the properties; or alleges that the Company or any Subsidiary is liable for any
contamination of the environment, contamination of the Property, damage to natural resources, property damage, or personal injury
based on their activities or the activities of their predecessors or third parties (whether at the properties or elsewhere) involving
Hazardous Materials, whether arising under the Environmental Laws, common law principles, or other legal standards. In the ordinary
course of its business, the Company and the Subsidiaries conduct Phase I environmental assessments on each of the Properties at
the time such Property is acquired and periodic reviews of the effect of Environmental Laws on the business, operations and properties
of the Company and the Subsidiaries.
(29)
Except as described in the Registration Statement, the Disclosure Package and the Prospectus,
there are no pending actions, suits or proceedings against or affecting the Company or any Subsidiary or any of their respective
Properties that, if determined adversely to the Company or such Subsidiary, would individually or in the aggregate have a Material
Adverse Effect, or would materially and adversely affect the ability of the Company to perform its obligations under this Agreement,
or which are otherwise material in the context of the offering, issuance, sale and delivery of the Securities; and no such actions,
suits or proceedings are, to the knowledge of the Company, threatened or contemplated.
(30)
The Company has implemented controls and other procedures that are designed to ensure that
information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded,
processed, summarized and reported, within the time periods specified in the Commission’s rules and forms and is accumulated
and communicated to the Company’s management, including its chief executive officer and chief financial officer, or persons
performing similar functions, as appropriate to allow timely decisions regarding required disclosure; and the Company makes and
keeps books, records, and accounts, which, in reasonable detail, accurately and fairly reflect the transactions and dispositions
of the assets of the Company; and the Company maintains a system of internal accounting controls sufficient to provide reasonable
assurances that (i) transactions are executed in accordance with management’s general or specific authorization; (ii) transactions
are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain accountability
for assets; (iii) access to assets is permitted only in accordance with management’s general or specific authorization; and
(iv) the recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate action is
taken with respect to any differences; and, to the Company’s knowledge, neither the Company nor any Subsidiary, nor any employee
or agent thereof, has made any payment of funds of the Company or any of the Subsidiaries, as the case may be, or received or retained
any funds, and no funds of the Company, or any of the Subsidiaries, as the case may be, have been set aside to be used for any
payment, in each case in violation of any law, rule or regulation.
(31)
Neither the Company nor any Subsidiary is and, after giving effect to the offering and sale
of the Securities and the application of the proceeds thereof as described in the Registration Statement, the Disclosure Package
and the Prospectus, neither will be an “investment company” or a company “controlled” by an “investment
company” within the meaning of the Investment Company Act of 1940, as amended.
(32)
The Company and the Subsidiaries have complied in all respects with all laws, regulations
and orders applicable to them or their respective businesses, except as would not have a Material Adverse Effect; neither the Company
nor any Subsidiary is in breach of, or in default under (nor has any event occurred which with notice, lapse of time, or both would
constitute a breach of, or default under), (A) its respective declaration of trust, by-laws, certificate of limited partnership,
partnership agreement or operating agreement, as the case may be, or (B) in the performance or observance of any material obligation,
agreement, covenant or condition contained in any material license, indenture, mortgage, deed of trust, loan or credit agreement
or other material agreement or instrument to which the Company or such Subsidiary is a party or by which any of them or their respective
properties is bound, except in the case of (B) where such breach, default or event would not have a Material Adverse Effect.
(33)
Each of the Company and the Subsidiaries has filed on a timely basis all necessary federal,
state, local and foreign income and franchise tax returns, if any such returns were required to be filed, through the date hereof
and have paid all taxes shown as due thereon, except where failure to so file or pay would not have a Material Adverse Effect;
and no tax deficiency has been asserted against the Company or any Subsidiary, nor, to the knowledge of the Company, is any tax
deficiency likely to be asserted against the Company or any Subsidiary; all tax liabilities, if any, are adequately provided for
on the respective books of the entities.
(34)
Commencing with its taxable year ended December 31, 1993, the Company has been organized
and operated in conformity with the requirements for qualification as a real estate investment trust (“REIT”)
under the Internal Revenue Code of 1986, as amended, and the regulations and published interpretations thereunder (the “Code”),
and the Company’s current and proposed method of operations will enable it to continue to meet the requirements for taxation
as a REIT under the Code; no transaction or other event has occurred which could reasonably be expected to cause the Company not
to be able to qualify as a REIT for its taxable years ending December 31, 2018 or future years.
(35)
Each of the Company and the Subsidiaries maintains insurance (issued by insurers of recognized
financial responsibility) of the types and in the amounts generally deemed adequate, if any, for their respective businesses and
consistent with insurance coverage maintained by similar companies in similar businesses, including, but not limited to, insurance
covering real and personal property owned or leased by the Company and the Subsidiaries against theft, damage, destruction, acts
of vandalism and all other risks customarily insured against, all of which insurance is in full force and effect.
(36)
There are no material outstanding loans or advances or material guarantees of indebtedness
by the Company or any Subsidiary to or for the benefit of any of the executive officers or trustees of the Company or any of their
family members.
(37)
The Company and its affiliates have not distributed and will not distribute, prior to the
completion of the Underwriters’ distribution of the Securities, any written offering materials in connection with the offer
and sale of the Securities other than (i) the Registration Statement, (ii) the Prospectus and (iii) the Issuer General Use Free
Writing Prospectuses set forth on Schedule II hereto, if any.
(38)
None of the entities which prepared appraisals of the Properties or Phase I environmental
assessment reports with respect to such Properties was employed for such purpose on a contingent basis or has any substantial interest
in the Company or any Subsidiary, and none of their trustees, managers, officers or employees is connected with the Company or
any Subsidiary as a promoter, selling agent, voting trustee, officer or employee.
(39)
The Company is in material compliance with applicable provisions of the Sarbanes-Oxley Act
of 2002, as amended from time to time.
(40)
The Company is in material compliance with the current listing standards of the NYSE and
has made all material filings and/or certifications to the NYSE on a timely basis.
(41)
The Company has implemented the “disclosure controls and procedures” (as defined
in Rules 13a-15(e) of the Exchange Act) required in order for the Chief Executive Officer and Chief Financial Officer of the Company
to engage in the review and evaluation process mandated by the Exchange Act. The Company’s “disclosure controls and
procedures” are reasonably designed to ensure that all information (both financial and non-financial) required to be disclosed
by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within
the specified time periods, and that all such information is accumulated and communicated to the Company’s management as
appropriate to allow timely decisions regarding required disclosure and to make the certifications of the Chief Executive Officer
and Chief Financial Officer of the Company required under the Exchange Act with respect to such reports.
(42)
The section entitled “Management’s Discussion and Analysis of Financial Condition
and Results of Operation—Critical Accounting Policies” in the Company’s most recent Annual Report on Form 10-K
and any of the Company’s Quarterly Reports on Form 10-Q filed subsequent to such Annual Report, which are incorporated by
reference into the Registration Statement, the Disclosure Package and the Prospectus, accurately and fully describes, or will when
filed accurately and fully describe, in each case in all material respects: (i) accounting policies which the Company believes
are the most important in the portrayal of the financial condition and results of operations of the Company and its consolidated
subsidiaries and which require management’s most difficult, subjective or complex judgments (“critical accounting
policies”), (ii) judgments and uncertainties affecting the application of critical accounting policies and (iii) the
explanation of the likelihood that materially different amounts would be reported under different conditions or using different
assumptions. The Company’s board of trustees, senior management and audit committee have reviewed and agreed with the selection,
application and disclosure of critical accounting policies and have consulted with the Company’s independent accountants
with regard to such disclosure.
(43)
Since the date of the filing of the Company’s most recent Annual Report on Form 10-K,
the Company’s auditors and the audit committee of the board of trustees of the Company (or persons fulfilling the equivalent
function) have not been advised of (i) any significant deficiencies in the design or operation of internal control over financial
reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report
financial reporting or (ii) fraud, whether or not material, that involves management or other employees who have a significant
role in the Company’s internal control over financial reporting.
(44)
Since the date of the filing of the Company’s most recent Annual Report on Form 10-K,
except as disclosed in the Registration Statement, the Disclosure Package and the Prospectus, there have been no significant changes
in internal control over financial reporting or in other factors that could significantly affect internal controls, including any
corrective actions with regard to significant deficiencies in such control over financial reporting.
(45)
Neither the Company’s nor any Subsidiary’s performance of its respective obligations
under its joint venture agreements nor the consummation of any transactions contemplated thereby nor the fulfillment of the terms
thereof by the Company or a Subsidiary will conflict with or, result in a breach or violation of (A) the charter, by-laws, partnership
agreement, operating agreement, limited liability company certificate or certificate of limited partnership of the Company or any
Subsidiary; (B) the terms of any material indenture, contract, lease, mortgage, deed of trust, note agreement, loan agreement or
other agreement, obligation, condition, covenant or instrument to which the Company or such Subsidiary is a party or bound or to
which its or their property is subject; or (C) any statute, law, rule, regulation, judgment, order or decree applicable to the
Company or any Subsidiary of any court, regulatory body, administrative agency, governmental body, arbitrator or other authority
having jurisdiction over the Company or such Subsidiary or any of its or their properties or, result in the creation or imposition
of any lien, charge, claim or encumbrance upon any property or asset of the Company or any Subsidiary, except in the case of (B)
and (C) where such conflict, breach, violation, creation or imposition, as the case may be, would not have a Material Adverse Effect.
(46)
The form of certificate used to evidence the Common Shares complies in all material respects
with all applicable statutory requirements, with any applicable requirements of the Declaration of Trust and By-laws of the Company
and the requirements of the NYSE.
(47)
The Securities will conform in all material respects to the respective statements relating
thereto contained in the Registration Statement, the Disclosure Package and the Prospectus. The Common Shares conform to all statements
relating thereto contained or incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus
and such description conforms to the rights set forth in the instruments defining the same.
(48)
Each of the Company and the Subsidiaries has not taken and will not take, directly or indirectly,
any action designed to or that would constitute or that might reasonably be expected to cause or result in the stabilization or
manipulation of the price of any security to facilitate the sale or resale of the Securities in violation of applicable law.
(49)
Neither the Company nor any Subsidiary, nor any trustee, director or officer of the Company
or any Subsidiary, nor, to the knowledge of the Company, any employee, agent, affiliate or other person acting on behalf of the
Company or any Subsidiary has, in the course of its actions for, or on behalf of, the Company or any such Subsidiary (i) used any
corporate funds for any unlawful contribution, gift, entertainment or other unlawful expenses relating to political activity; (ii)
made or taken any act in furtherance of an offer, promise, or authorization of any direct or indirect unlawful payment or benefit
to any foreign or domestic government official or employee, including of any government-owned or controlled entity or public international
organization, or any political party, party official, or candidate for political office; (iii) violated or is in violation of any
provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended (the “FCPA”), the UK Bribery Act 2010,
or any other applicable anti-bribery or anti-corruption law; or (iv) made, offered, authorized, requested, or taken an act in furtherance
of any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful payment or benefit. The Company and the Subsidiaries
and, to the knowledge of the Company, their affiliates, have conducted their respective businesses in compliance with the FCPA
and have instituted and maintain policies and procedures designed to ensure, and which are reasonably expected to continue to ensure,
continued compliance therewith.
(50)
The operations of the Company and the Subsidiaries are and have been conducted at all times
in compliance with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting
Act of 1970, as amended, the money laundering statutes of all jurisdictions, the rules and regulations thereunder and any related
or similar rules, regulations or guidelines, issued, administered or enforced by any governmental entity (collectively, the “Money
Laundering Laws”); and no action, suit or proceeding by or before any governmental entity involving the Company or any
of the Subsidiaries with respect to the Money Laundering Laws is pending or, to the best knowledge of the Company, threatened.
(51)
Neither the Company nor any of the Subsidiaries, directors or officers, nor, to the knowledge
of the Company, any employee, agent, affiliate or other person acting on behalf of the Company or any of the Subsidiaries is currently
the subject or the target of any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Department of
the Treasury (“OFAC”) or the U.S. Department of State, the United Nations Security Council, the European Union,
Her Majesty’s Treasury of the United Kingdom, or other relevant sanctions authority (collectively, “Sanctions”);
nor is the Company or any of the Subsidiaries located, organized or resident in a country or territory that is the subject or target
of Sanctions, including, without limitation, Crimea, Cuba, Iran, North Korea, and Syria (each, a “Sanctioned Country”);
and the Company and the Subsidiaries will not directly or indirectly use the proceeds from the sale of Common Shares under this
Agreement, or lend, contribute or otherwise make available such proceeds to any subsidiary, or any joint venture partner or other
person or entity, for the purpose of financing the activities of or business with any person, or in any country or territory, that
at the time of such financing, is the subject or target of Sanctions or in any other manner that will result in a violation by
any person (including any person participating in the transaction whether as underwriter, advisor, investor or otherwise) of applicable
Sanctions. For the past five years, the Company and the Subsidiaries have not knowingly engaged in and are not now knowingly engaged
in any dealings or transactions with any person that at the time of the dealing or transaction is or was the subject or the target
of Sanctions or with any Sanctioned Country.
(52)
Except as set forth in the Company’s financial statements, each of the Company and
the Subsidiaries do not have any material liabilities under the Employee Retirement Income Security Act of 1974, as amended and
the regulations and published interpretations thereunder (collectively, “ERISA”), or Section 4975 of the Code.
(53)
Any statistical and market-related data included in the Registration Statement, the Disclosure
Package or the Prospectus are based on or derived from sources that the Company believes, after reasonable inquiry, to be reliable
and accurate and, to the extent required, the Company has obtained the written consent to the use of such data from such sources.
(54)
Except as disclosed in the Registration Statement, the Disclosure Package and the Prospectus,
the Company does not intend to use any of the proceeds from the sale of the Securities to repay any debt owed to the Underwriters
or any of their affiliates.
(55)
All of the information provided pursuant to this Agreement, if any, to the Underwriters
or to counsel for the Underwriters by the Company, its officers and directors and the holders of any securities (debt or equity)
or options to acquire any securities of the Company in connection with letters, filings or other supplemental information provided
to FINRA pursuant to FINRA Rules 5110, 5190 and NASD Conduct Rule 2720 is true, complete and correct in all material respects.
The Company meets the requirements for use of Form S-3 under the Securities Act specified in FINRA Rule 5110(b)(7)(C)(i). Neither
the Company nor any of its Affiliates directly, or indirectly through one or more intermediaries, controls, or is controlled by,
or is under common control with, or is a person associated with any member firm of FINRA.
(56)
Neither the Company nor any Subsidiary nor, to the best of the Company’s knowledge,
any employee or agent of the Company or any Subsidiary, has made any contribution or other payment to any official of, or candidate
for, any federal, state or foreign office in violation of any law or of the character required to be disclosed in the Registration
Statement, the Disclosure Package and the Prospectus.
(57)
Except as otherwise disclosed in the Prospectus, the Company and the Subsidiaries and any
“employee benefit plan” (as defined under ERISA) established or maintained by the Company or such Subsidiary or their
“ERISA Affiliates” (as defined below) are in compliance in all material respects with ERISA. “ERISA Affiliate”
means, with respect to the Company and the Subsidiaries, any member of any group of organizations described in Sections 414(b),
(c), (m) or (o) of the Code of which the Company or the Subsidiary is a member. No “reportable event” (as defined under
ERISA) has occurred or is reasonably expected to occur with respect to any “employee benefit plan” established or maintained
by the Company, the Subsidiaries or any of their ERISA Affiliates. No “employee benefit plan” established or maintained
by the Company, the Subsidiaries or any of their ERISA Affiliates, if such “employee benefit plan” were terminated,
would have any “amount of unfunded benefit liabilities” (as defined under ERISA). Neither the Company, nor the Subsidiaries
nor any of their ERISA Affiliates has incurred or reasonably expects to incur any liability under (i) Title IV of ERISA with respect
to termination of, or withdrawal from, any “employee benefit plan” or (ii) Sections 412, 4971, 4975 or 4980B of the
Code. Each “employee benefit plan” established or maintained by either the Company, the Subsidiaries or any of their
ERISA Affiliates that is intended to be qualified under Section 401(a) of the Code is so qualified and nothing has occurred, whether
by action or failure to act, which would cause the loss of such qualification.
(58)
Each financial or operational projection or other “forward-looking statement”
(as defined by Section 27A of the Securities Act or Section 21E of the Exchange Act) contained in the Registration Statement, the
Disclosure Package or the Prospectus (i) was so included by the Company in good faith and with reasonable basis after due consideration
by the Company of the underlying assumptions, estimates and other applicable facts and circumstances and (ii) is accompanied by
meaningful cautionary statements identifying those factors that could cause actual results to differ materially from those in such
forward-looking statement. No such statement was made with the knowledge of an executive officer or director of the Company that
is was false or misleading.
(59)
The Company and the Subsidiaries’ material information technology assets and equipment,
computers, systems, networks, hardware, software, websites, applications, and databases (collectively, “IT Systems”)
are adequate for, and operate and perform in all material respects as required in connection with the operation of the business
of the Company and its Subsidiaries as currently conducted, and to the knowledge of the Company, free and clear of all material
bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants. The Company and its Subsidiaries have implemented
and maintained commercially reasonable physical, technical and administrative controls, policies, procedures, and safeguards to
maintain and protect their material confidential information and the integrity, continuous operation, redundancy and security of
all IT Systems and data, including “Personal Data,” used in connection with their businesses. “Personal Data”
means a natural person’s name, street address, telephone number, e-mail address, photograph, social security number or tax
identification number, driver’s license number, passport number, credit card number, bank information, or any other piece
of information that reasonably allows for the identification of such natural person or his or her family. There have been no breaches,
violations, outages or unauthorized uses of or accesses to same, except for those that have been remedied without material cost
or liability or the duty to notify any other person, nor any incidents under internal review or investigations relating to the
same, except for those that may be remedied without any material cost to the Company. The Company and its Subsidiaries are presently
in material compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator
or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of
IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from unauthorized use, access, misappropriation
or modification.
(60)
The Company and its Subsidiaries are in material compliance with all applicable state and
federal data privacy and security laws and regulations (collectively, the “Privacy Laws”). To ensure compliance
with the Privacy Laws, the Company and its Subsidiaries have in place, comply with, and take appropriate steps reasonably designed
to ensure compliance in all material respects with their policies and procedures relating to data privacy and security and the
collection, storage, use, disclosure, handling, and analysis of Personal Data (the “Policies”). The Company
and its Subsidiaries have at all times made all disclosures to users or customers required by applicable laws and regulatory rules
or requirements, and none of such disclosures made or contained in any Policy have, to the knowledge of the Company, been inaccurate
or in violation of any applicable laws and regulatory rules or requirements in any material respect. The Company further certifies
that neither it nor any Subsidiary, to the knowledge of the Company: (i) has received notice of any actual or potential liability
under or relating to, or actual or potential violation of, any of the Privacy Laws, and has no knowledge of any event or condition
that would reasonably be expected to result in any such notice; (ii) is currently conducting or paying for, in whole or in part,
any investigation, remediation, or other corrective action pursuant to any Privacy Law; or (iii) is a party to any order, decree,
or agreement that imposes any obligation or liability under any Privacy Law.
(b)
Certificates. Any certificate signed by any officer of the Company or any of its
Subsidiaries and delivered to the Underwriters or to counsel for the Underwriters shall be deemed a representation and warranty
by the Company or such Subsidiary to the Underwriters as to the matters covered thereby.
Section
3. Sale and Delivery to The Underwriters; Closing.
(a)
Sale of Initial Securities. On the basis of the representations and warranties herein
contained and subject to the terms and conditions herein set forth, the Company agrees to sell to each Underwriter, and each Underwriter,
severally and not jointly, agrees to purchase from the Company, at a price of $10.09 per share (the “Purchase Price”),
the Initial Securities in the respective amounts set forth opposite the names of the Underwriters listed on Schedule I hereto.
The Underwriters hereby acknowledge that they propose to resell all of the Initial Securities.
(b)
Option Securities. In addition, on the basis of the representations and warranties
herein contained and subject to the terms and conditions set forth herein, the Company hereby grants an option to the Underwriters,
acting severally and not jointly, to purchase up to 1,500,000 additional Common Shares at a price per share equal to the Purchase
Price referred to in Section 3(a) above. The option hereby granted will expire at the close of business on the 30th day
after the date hereof and may be exercised in whole or in part from time to time upon notice by the Underwriters to the Company
setting forth the number of Option Securities as to which the Underwriters are then exercising the option and the time and date
of payment and delivery for such Option Securities. Any such time and date of delivery (an “Option Closing Date”)
shall be determined by the Underwriters, and may be the Closing Date (as hereinafter defined), but shall not be earlier than three
full business days or later than seven full business days after the exercise of said option, nor in any event prior to the Closing
Date. If the option is exercised as to all or any portion of the Option Securities, the Company will sell to the Underwriters the
total number of Option Securities then being purchased, and the Underwriters will, acting severally and not jointly, purchase the
total number of Option Securities in amounts that are proportionate to the number of Initial Securities that the Underwriters have
agreed to purchase hereunder as set forth on Schedule I hereto, subject, however, to such adjustments to eliminate fractional
shares as the Underwriters in their sole discretion shall make.
(c)
Payment. Payment of the purchase price for, and delivery of certificates for, the
Initial Securities shall be made at the offices of Goodwin Procter LLP, 620 Eighth Avenue, New York, NY 10018 or at such other
place as shall be agreed upon by the Underwriters and the Company, at 9:00 A.M. (New York City time) on September 9, 2019, unless
postponed to such other time not later than ten business days after such date as shall be agreed upon by the Underwriters and the
Company (such time and date of payment and delivery being herein called the “Closing Date”). In addition, in
the event that any or all of the Option Securities are purchased by the Underwriters, payment of the purchase price for, and delivery
of certificates for, such Option Securities shall be made at 9:00 A.M. at the above-mentioned offices, or at such other place as
shall be agreed upon by the Underwriters and the Company, on each Option Closing Date as specified in the notice from the Underwriters
to the Company. Payment shall be made to the Company by wire transfer of immediately available funds to bank account(s) designated
by the Company against delivery to the Underwriters of the Securities to be purchased by them.
(d)
Denominations; Registration. Certificates for any certificated Initial Securities
and the Option Securities, if any, shall be in such denominations and registered in such names as the Underwriters may request
in writing at least one full business day before the Closing Date or the relevant Option Closing Date, as the case may be. The
certificates for the Initial Securities and the Option Securities, if any, will be made available for examination and packaging
by the Underwriters in the City of New York not later than noon (New York time) on the business day prior to the Closing Date or
the relevant Option Closing Date, as the case may be.
Section
4. Covenants of the Company. The Company covenants with the Underwriters
as follows:
(a)
Compliance with Securities Regulations and Commission Requests. Prior to the first
to occur of the final Option Closing Date or the expiration of the option set forth in Section 3(b), the Company, subject
to Section 3(b), will comply with the requirements of Rule 430B, and will promptly notify the Underwriters, and confirm
the notice in writing, (i) when any post-effective amendment to the Registration Statement shall become effective, or any supplement
to the Prospectus or any amended Prospectus shall have been filed, (ii) of the receipt of any comments from the Commission, (iii)
of any request by the Commission for any amendment to the Registration Statement or any amendment or supplement to the Prospectus
or any document incorporated by reference therein or for additional information, (iv) of the issuance by the Commission of any
stop order suspending the effectiveness of the Registration Statement or of any order preventing or suspending the use of any preliminary
prospectus, or of the suspension of the qualification of the Securities for offering or sale in any jurisdiction, or of the initiation
or threatening of any proceedings for any of such purposes or of any examination pursuant to Section 8(e) of the Securities Act
concerning the Registration Statement and (v) if the Company becomes the subject of a proceeding under Section 8A of the Securities
Act in connection with the offering of the Securities. The Company will effect the filings required under Rule 424(b), in the manner
and within the time period required by Rule 424(b) (without reliance on Rule 424(b)(8)), and will take such steps as it deems necessary
to ascertain promptly whether the form of prospectus transmitted for filing under Rule 424(b) was received for filing by the Commission
and, in the event that it was not, it will promptly file such prospectus. The Company will make every reasonable effort to prevent
the issuance of any stop order and, if any stop order is issued, to obtain the lifting thereof at the earliest possible moment.
(b)
Filing of Amendments and Exchange Act Documents. Prior to the first to occur of the
final Option Closing Date or the expiration of the option set forth in Section 3(b), the Company will give the Underwriters
notice of its intention to file or prepare any amendment to the Registration Statement or any amendment, supplement or revision
to either any preliminary prospectus or to the Prospectus, whether pursuant to the Securities Act, the Exchange Act or otherwise,
and the Company will furnish the Underwriters with copies of any such documents a reasonable amount of time prior to such proposed
filing or use, as the case may be, and will not file or use any such document to which the Underwriters or counsel for the Underwriters
shall reasonably object. The Company has given the Underwriters notice of any filings made pursuant to the Exchange Act within
forty-eight (48) hours prior to the execution of this Agreement; the Company will give the Underwriters notice of its intention
to make any such filing from the execution of this Agreement to the Closing Date and will furnish the Underwriters with copies
of any such documents a reasonable amount of time prior to such proposed filing and will not file or use any such document to which
the Underwriters or counsel for the Underwriters shall reasonably object.
(c)
Delivery of Registration Statements. Upon request, the Company will deliver to the
Underwriters and counsel for the Underwriters, without charge, a signed copy of the Registration Statement as originally filed
and of each amendment thereto (including exhibits filed therewith) and signed copies of all consents and certificates of experts.
The copies of such Registration Statement and each amendment thereto furnished to the Underwriters and counsel for the Underwriters
will be identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent
permitted by Regulation S-T.
(d)
Delivery of Prospectuses. The Company will deliver to the Underwriters, without charge,
during the period when the Prospectus is required to be delivered under the 1933 Act in connection with the sales of the Securities
(the “Prospectus Delivery Period”), such number of copies of the Prospectus (as amended or supplemented) as
the Underwriters may reasonably request and the Company hereby consents to the use of such copies for purposes permitted by the
1933 Act. The Prospectus and any amendments or supplements thereto furnished to the Underwriters will be identical to the electronically
transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T.
(e)
Continued Compliance with Securities Laws. The Company shall comply with the Securities
Act and the Exchange Act so as to permit the completion of the distribution of the Securities as contemplated in this Agreement
and the Prospectus. If at any time during the Prospectus Delivery Period, any event shall occur or condition shall exist as a result
of which it is necessary, in the opinion of counsel for the Underwriters or for the Company, to amend the Registration Statement
or amend or supplement the Prospectus in order that the Prospectus will not include any untrue statement of a material fact or
omit to state a material fact necessary in order to make the statements therein not misleading, in the case of the Prospectus,
in the light of the circumstances existing at the time it is delivered to a purchaser, or if it shall be necessary, in the opinion
of such counsel, at any such time to amend the Registration Statement or amend or supplement the Prospectus in order to comply
with the requirements of the Securities Act, the Company will promptly prepare and file with the Commission, subject to Section
4(b) hereof, such amendment or supplement as may be necessary to correct such statement or omission or to make the Registration
Statement or the Prospectus comply with such requirements, the Company will use its best efforts to have any such amendment to
the Registration Statement declared effective as soon as practicable, and the Company will furnish to the Underwriters such number
of copies of such amendment or supplement as the Underwriters may reasonably request. If at any time following the issuance of
an Issuer Free Writing Prospectus there occurred or occurs, prior to the completion of the distribution of the Securities by the
Underwriters, an event or development as a result of which such Issuer Free Writing Prospectus conflicted, conflicts or would conflict
with the information contained in the Registration Statement, any preliminary prospectus or the Prospectus or, together with the
Registration Statement, the Disclosure Package and Prospectus, taken as a whole, included, includes or would include an untrue
statement of a material fact or omitted, omits or would omit to state a material fact necessary in order to make the statements
therein, in the light of the circumstances, prevailing at that subsequent time, not misleading, the Company will promptly notify
the Underwriters, and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or
correct such conflict, untrue statement or omission.
(f)
Permitted Free Writing Prospectuses. The Company agrees that, unless it obtains the
prior written consent of the Underwriters, and each Underwriter agrees that, unless it obtains the prior written consent of the
Company, it will not make any offer relating to the Securities that would constitute an “issuer free writing prospectus”
as defined in Rule 433, or that would otherwise constitute a “free writing prospectus,” as defined in Rule 405 of the
Securities Act, required to be filed with the Commission; provided that the prior written consent of the Underwriters or the
Company, as the case may be, shall be deemed to have been given in respect of any Issuer General Use Free Writing Prospectuses
listed in Schedule II hereto. Any such free writing prospectus consented to by the Underwriters or the Company and the Underwriters,
as the case may be, is hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i)
it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an “issuer free writing prospectus,”
as defined in Rule 433, and (ii) has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of
the Securities Act applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission,
legending and record keeping.
(g)
Blue Sky Qualifications. The Company will use its commercially reasonable efforts,
in cooperation with the Underwriters, to qualify the Securities for offering and sale under the applicable securities laws of such
states and other jurisdictions (domestic or foreign) as the Underwriters may designate and to maintain such qualifications in effect
so long as required to complete the distribution of the Securities; provided, however, that the Company shall not be obligated
to file any general consent to service of process or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction
in which it is not so qualified or to subject itself to taxation in respect of doing business in any jurisdiction in which it is
not otherwise so subject.
(h)
Rule 158. The Company will timely file such reports pursuant to the Exchange Act
as are necessary in order to make generally available to its security holders as soon as practicable an earnings statement for
the purposes of, and to provide to the Underwriters the benefits contemplated by, the last paragraph of Section 11(a) of the Securities
Act.
(i)
Use of Proceeds. The Company will use the net proceeds received by it from the sale
of the Securities in the manner specified in the Disclosure Package and the Prospectus under “Use of Proceeds.”
(j)
DTCC. The Company will cooperate with the Underwriters and use its best efforts to
permit the Securities to be eligible for clearance and settlement through the facilities of The Depository Trust & Clearing
Corporation (“DTCC”).
(k)
Listing. The Company will use its best efforts to effect the listing of the Securities
on the NYSE.
(l)
Restriction on Sale of Securities. During a period of 45 days from the date of the
Prospectus (the “Lock-Up Period”), the Company will not, without the prior written consent of the Underwriters,
(i) directly or indirectly, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option
or contract to sell, grant any option, right or warrant to purchase or otherwise transfer or dispose of any Common Shares or any
securities convertible into or exercisable or convertible for Common Shares or file any registration statement under the Securities
Act with respect to any of the foregoing; provided, however, that the foregoing restrictions shall not prohibit the Company from
filing a shelf registration statement or a prospectus or any amendment or supplement thereto under the Securities Act relating
to an “at the market” offering of its Common Shares after the Closing Date so long as no offers or sales are made by
the Company pursuant thereto during the Lock-Up Period, or (ii) enter into any swap or any other agreement or any transaction that
transfers, in whole or in part, directly or indirectly, the economic consequence of ownership of the Common Shares, whether any
such swap or transaction described in clause (i) or (ii) above is to be settled by delivery of Common Shares or such other securities,
in cash or otherwise. The foregoing sentence shall not apply to (A) the Securities to be sold hereunder, (B) any Common Shares
issued by the Company upon (x) the exercise of an option or warrant or (y) the conversion of a security, in either case outstanding
on the date hereof and referred to (by incorporation by reference or otherwise) in the Disclosure Package and the Prospectus, (C)
any Common Shares issued or options to purchase Common Shares granted pursuant to existing employee benefit plans of the Company
referred to in the Disclosure Package and the Prospectus, (D) any Common Shares issued pursuant to any non-employee director stock
plan, direct stock purchase plan or dividend reinvestment plan referred to in the Disclosure Package and the Prospectus, (E) any
limited partner interests in LCIF (“OP Units”) that are issued in exchange for real property or interests therein
in the ordinary course of business, or (F) any Common Shares issuable upon conversion of OP Units. Notwithstanding the foregoing,
in the event that either (x) during the last 17 days of the Lock-Up Period, the Company issues an earnings release or (y) prior
to the expiration of such Lock-Up Period, the Company announces that it will release earnings results during the 16-day period
beginning on the last day of such Lock-Up Period, the restrictions described above shall continue to apply until the expiration
of the 18-day period beginning on the date of the earnings release.
(m)
Reporting Requirements. The Company, during the Prospectus Delivery Period, will
file all documents required to be filed with the Commission pursuant to, and in accordance with, the Exchange Act within the time
periods required by the Exchange Act.
(n)
Preparation of Prospectus. Immediately following the execution of this Agreement,
the Company will, subject to Section 4(b) hereof, prepare the Prospectus containing the Rule 430B Information and other
selling terms of the Securities, the plan of distribution thereof and such other information as may be required by the Securities
Act or as the Underwriters and the Company may deem appropriate, and will file or transmit for filing with the Commission, in accordance
with Rule 424(b), copies of the Prospectus.
(o)
REIT Qualification. The Company will use its best efforts to continue to meet the
requirements to qualify as a “real estate investment trust” under the Code for so long as the Company intends to so
qualify.
(p)
Company Not an “Investment Company”. The Company is familiar with the
Investment Company Act and will in the future conduct its and each of its Subsidiaries’ affairs in such a manner so as to
reasonably ensure that neither it nor its Subsidiaries will be required to register as an “investment company,” as
such term is defined in the Investment Company Act.
(q)
No Price Stabilization or Manipulation. The Company will not, directly or indirectly,
and will use its best efforts to cause its officers, trustees and affiliates not to, prior to the completion of the distribution
of the Securities by the Underwriters contemplated by this Agreement, (i) take, directly or indirectly any action designed to stabilize
or manipulate the price of any security of the Company, or which may cause or result in, or which might in the future reasonably
be expected to cause or result in, the stabilization or manipulation of the price of any security of the Company, to facilitate
the sale or resale of any of the Securities or (ii) sell, bid for, purchase or pay anyone (other than the Underwriters) any compensation
for soliciting purchases of the Securities.
Section
5. Payment of Expenses.
(a)
Expenses. The Company will pay all expenses incident to the performance of its obligations
under this Agreement, including (i) the preparation, printing and filing of the Registration Statement (including financial statements
and any schedules or exhibits) as originally filed and of each amendment and supplement thereto, (ii) the word processing, printing
and delivery to the Underwriters of this Agreement and such other documents as may be required in connection with the offering,
purchase, sale, issuance or delivery of the Securities, (iii) the preparation, issuance and delivery of the certificates for the
Securities to the Underwriters and any charges of DTCC in connection therewith, including any stock or other transfer taxes and
any capital duties, stamp duties or other similar duties or taxes payable upon the sale, issuance or delivery of the Securities
(other than taxes on the income or commissions of the Underwriters) to the Underwriters, (iv) the fees and disbursements of the
counsel, accountants and other advisors to the Company, (v) the qualification or exemption of the Securities under securities laws
in accordance with the provisions of Section 4(d) hereof, including filing fees and the reasonable fees and disbursements
of counsel for the Underwriters, (vi) the delivery to the Underwriters of copies of the Prospectus and any amendments or supplements
thereto and any costs associated with electronic delivery of any of the foregoing by the Underwriters to investors, (vii) the preparation,
printing and delivery to the Underwriters of copies of the Blue Sky Survey and any supplement thereto, (viii) the fees and expenses
of the Custodian and the transfer agent and registrar for the Securities, (ix) the filing fees incident to, and the reasonable
fees and disbursements of counsel to the Underwriters in connection with, the review by FINRA of the terms of the sale of the Securities,
and (x) the fees and expenses incurred in connection with the listing of the Securities on the NYSE.
(b)
Termination of Agreement. If this Agreement is terminated by the Underwriters in
accordance with the provisions of Section 6(o) (other than due to the failure to satisfy any conditions therein due to events
set forth in Sections 10(a)(ii), (iv), (v) and (vi)) or Section 10(a)(i) or Section 10(a)(iii)
hereof (other than due to events set forth in Sections 10(a)(ii), (iv), (v) and (vi))), the Company
shall reimburse the Underwriters for all of their reasonable out-of-pocket expenses, including the reasonable fees and disbursements
of counsel for the Underwriters.
Section
6. Conditions of the Underwriters’ Obligations. The several obligations
of the Underwriters hereunder will be subject to the accuracy and completeness of the representations and warranties of the Company
contained herein or in certificates of any officer of the Company or any of its Subsidiaries of the Company delivered pursuant
to the provisions hereof, to the performance by the Company of its covenants and other obligations hereunder, and to the following
further conditions:
(a)
No Stop Orders; Filing of Prospectus. The Registration Statement has become effective
and at the Closing Date (or the applicable Option Closing Date, as the case may be), no stop order suspending the effectiveness
of the Registration Statement shall have been issued under the Securities Act or proceedings therefor initiated or, to the knowledge
of the Company, threatened by the Commission, and any request on the part of the Commission for additional information shall have
been complied with to the satisfaction of counsel to the Underwriters. The Prospectus shall have been filed with the Commission
pursuant to Rule 424(b) within the time period prescribed by such Rule, and prior to the Closing Date, the Company shall have provided
evidence satisfactory to the Underwriters of such timely filing and such number of copies of the Prospectus as the Underwriters
shall have reasonably requested.
(b)
No Material Adverse Change. At the Closing Date (or the applicable Option Closing
Date, as the case may be), there shall not have been, since the date hereof or since the respective dates as of which information
is given in the Prospectus (exclusive of any amendments or supplements thereto subsequent to the date of this Agreement), any material
adverse change in the condition, financial or otherwise, or in the earnings, investment portfolio, business affairs or business
prospects of the Company, LCIF and the other Subsidiaries considered as one enterprise, whether or not arising in the ordinary
course of business.
(c)
Opinions of Counsel for Company. Paul Hastings LLP, counsel for the Company, shall
have furnished to the Underwriters, at the request of the Company, their written opinion, dated the Closing Date, and addressed
to the Underwriters, including customary opinions and in a form reasonably acceptable to the Underwriters, and their negative assurance
letter, dated the Closing Date, and addressed to the Underwriters, in a form reasonably acceptable to the Underwriters. Venable
LLP, Maryland counsel for the Company, shall have furnished to the Underwriters, at the request of the Company, their written opinion,
dated the Closing Date, and addressed to the Underwriters, substantially in the form of Exhibit D. Paul Hastings LLP, tax
counsel for the Company, shall have furnished to the Underwriters, at the request of the Company, their written tax opinion, dated
the Closing Date, and addressed to the Underwriters, including customary opinions and in a form reasonably acceptable to the Underwriters.
(d)
Opinion of Counsel for Underwriters. At the Closing Date, the Underwriters shall
have received an opinion, dated as of the Closing Date, of Goodwin Procter LLP, counsel for the Underwriters, with respect to the
issuance and sale of the Securities, the Registration Statement, the Disclosure Package and the Prospectus and such other related
matters as the Underwriters may reasonably request. In giving such opinion, Goodwin Procter LLP may rely without investigation,
as to all matters arising under or governed by the laws of the State of Maryland, on the opinion of Venable LLP referred to in
Section 6(d) above.
(e)
Officer Certificate. At the Closing Date, the Underwriters shall have received a
certificate of the Chief Executive Officer and the Chief Financial Officer of the Company, dated as of the Closing Date, substantially
in the form of Exhibit C, to the effect that (i) there has been no material adverse change as described in Section 6(b)
above, (ii) the representations and warranties of the Company in this Agreement are true and correct with the same force and effect
as though expressly made at and as of the Closing Date, (iii) the obligations of the Company to be performed at or prior to the
Closing Date under or pursuant to this Agreement have been duly performed, (iv) no stop order suspending the effectiveness of the
Registration Statement has been issued and no proceedings for that purpose have been instituted or are pending or, to their knowledge,
contemplated by the Commission and (v) none of the Registration Statement, as of the date it first became effective, as of each
deemed effective date with respect to the Underwriters pursuant to Rule 430B(f)(2) of the Securities Act or as of the Closing Date,
or the Disclosure Package, as of the Initial Sale Time, or the Prospectus, as of its date or as of the Closing Date, contained
or contains an untrue statement of a material fact or omitted or omits to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading.
(f)
CFO Certificate. At the execution of this Agreement, the Underwriters shall have
received a certificate of the Chief Financial Officer of the Company, dated such date, substantially in the form of Exhibit
E.
(g)
Bring-down CFO Certificate. At the Closing Date, the Underwriters shall have received
a certificate of the Chief Financial Officer of the Company, dated as of the Closing Date, to the effect that she reaffirms the
statements made in the letters furnished pursuant to subsection (g) of this Section 6.
(h)
Accountant’s Comfort Letter. At the time of the execution of this Agreement,
the Underwriters shall have received from Deloitte & Touche LLP, a letter, dated such date, in form and substance satisfactory
to the Underwriters, containing statements and information of the type ordinarily included in accountant’s “comfort
letters” to underwriters with respect to the financial statements and certain financial information contained in the Registration
Statement, the Disclosure Package and the Prospectus.
(i)
Bring-down Comfort Letter. At the Closing Date, the Underwriters shall have received
from Deloitte & Touche LLP, a letter, dated as of the Closing Date, to the effect that they reaffirm the statements made in
the letters furnished pursuant to subsection (i) of this Section 6, except that the “specified date” referred
to shall be a date not more than one business day prior to the Closing Date.
(j)
Approval for Listing. At the Closing Date and each Option Closing Date, if any, the
Securities shall have been approved for listing on the New York Stock Exchange, subject only to official notice of issuance.
(k)
Lock-up Agreements. At the date of this Agreement, the Underwriters shall have received
an agreement substantially in the form of Exhibit A hereto signed by each person listed in Schedule IV hereto.
(l)
Maintenance of Rating. Since the execution of this Agreement, there shall not have
been any decrease in or withdrawal of the rating of any securities of the Company or any of its subsidiaries by any “nationally
recognized statistical rating organization” (as defined for purposes of Rule 436(g) under the 1933 Act) or any notice given
of any intended or potential decrease in or withdrawal of any such rating or of a possible change in any such rating that does
not indicate the direction of the possible change.
(m)
Conditions to Purchase of Option Securities. In the event that the Underwriters exercise
their option provided in Section 3(b) hereof to purchase all or any portion of the Option Securities on any Option Closing
Date that is after the Closing Date, the obligations of the Underwriters to purchase the applicable Option Securities shall be
subject to the conditions specified in the introductory paragraph of this Section 6 and to the further condition that, at
the applicable Option Closing Date, the Underwriters shall have received:
(1)
Officers’ Certificate. A certificate, dated such Option Closing Date, to the
effect set forth in, and signed by the Chief Executive Officer and the Chief Financial Officer of the Company, as specified in
Section 6(f) hereof, except that the references in such certificate to the Closing Date shall be changed to refer to such
Option Closing Date.
(2)
Opinions of Counsel for the Company. The opinions of (i) Paul Hastings LLP and (ii)
Venable LLP, in form and substance satisfactory to counsel for the Underwriters, dated such Option Closing Date, relating to the
Option Securities to be purchased on such Option Closing Date and otherwise to the same effect as the opinions required by Section
6(d) hereof.
(3)
Opinion of Counsel for Underwriters. The opinion of Goodwin Procter LLP, counsel
for the Underwriters, dated such Option Closing Date, relating to the Option Securities to be purchased on such Option Closing
Date and otherwise to the same effect as the opinion required by Section 6(e) hereof.
(4)
Bring-down Comfort Letter. A letter from Deloitte & Touche LLP, in form and substance
satisfactory to the Underwriters and dated such Option Closing Date, substantially in the same form and substance as the letters
furnished to the Underwriters pursuant to Section 6(j) hereof, except that the “specified date” in the letter
furnished pursuant to this paragraph shall be a date not more than one business day prior to such Option Closing Date.
(5)
Bring-down CFO Certificate. A certificate, dated such Option Closing Date, to the
effect set forth in, and signed by the Chief Financial Officer of the Company, as specified in Section 6(h) hereof, except
that the references in such certificate to the Closing Date shall be changed to refer to such Option Closing Date.
(n)
Additional Documents. At the Closing Date and at each Option Closing Date, counsel
for the Underwriters shall have been furnished with such other documents and opinions as they may reasonably require for the purpose
of enabling them to pass upon the issuance and sale of the Securities as herein contemplated, or in order to evidence the accuracy
of any of the representations or warranties, or the fulfillment of any of the conditions, contained in this Agreement; and all
proceedings taken by the Company in connection with the issuance and sale of the Securities as herein contemplated shall be satisfactory
in form and substance to the Underwriters and counsel for the Underwriters.
(o)
Termination of Agreement. If any condition specified in this Section 6 shall
not have been fulfilled when and as required to be fulfilled, this Agreement, or, in the case of any condition to the purchase
of Option Securities on an Option Closing Date which is after the Closing Date, the obligations of the Underwriters to purchase
the relevant Option Securities, may be terminated by the Underwriters by notice to the Company at any time on or prior to the Closing
Date or such Option Closing Date, as the case may be, and such termination shall be without liability of any party to any other
party except as provided in Section 5 hereof, and except that Sections 2, 7, 8, 9, 13,
14 and 17 hereof shall survive any such termination and remain in full force and effect.
Section
7. Indemnification and Contribution.
(a)
Indemnification of Underwriters. The Company agrees to indemnify and hold harmless
each of the Underwriters, their respective officers and employees, their respective affiliates, as such term is defined in Rule
501(b) under the Securities Act (each, an “Affiliate”), their respective selling agents and each person, if
any, who controls each Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act as
follows:
(1)
against any and all loss, liability, claim, damage and expense whatsoever, as incurred,
arising out of any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement (or
any amendment thereto), including the Rule 430B information, or the omission or alleged omission therefrom of a material fact required
to be stated therein or necessary to make the statements therein not misleading or arising out of any untrue statement or alleged
untrue statement of a material fact included in any preliminary prospectus, any Issuer Free Writing Prospectus or the Prospectus
(or any amendment or supplement thereto), or the omission or alleged omission therefrom of a material fact necessary in order to
make the statements therein, in the light of the circumstances under which they were made, not misleading;
(2)
against any and all loss, liability, claim, damage and expense whatsoever, as incurred,
to the extent of the aggregate amount paid in settlement of any litigation, or any investigation or proceeding by any governmental
agency or body, commenced or threatened, or of any claim whatsoever based upon any such untrue statement or omission or any such
alleged untrue statement or omission; provided that (subject to Section 7(d) below) any such settlement is effected with
the written consent of the Company;
(3)
against any and all expense whatsoever, as incurred (including the fees and disbursements
of counsel chosen by the Underwriters), reasonably incurred in investigating, preparing or defending against any litigation, or
any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon
any such untrue statement or omission, or any such alleged untrue statement or omission, to the extent that any such expense is
not paid under (1) or (2) above;
provided, however,
that this indemnity agreement shall not apply to any loss, liability, claim, damage or expense to the extent arising out of any
untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with written information
furnished to the Company by or on behalf of any of the Underwriters expressly for use in the Registration Statement (or any amendment
thereto), including the Rule 430B information, or any preliminary prospectus, or any Issuer Free Writing Prospectus or the Prospectus
(or any amendment or supplement thereto), which information is described in Section 2(a)(1) hereof.
(b)
Indemnification of Company, Trustees and Officers. Each Underwriter, severally and
not jointly, agrees to indemnify and hold harmless the Company, its trustees, its officers and each person, if any, who controls
the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, against any and all loss,
liability, claim, damage and expense described in the indemnity contained in subsection (a) of this Section 7, as incurred,
but only with respect to untrue statements or omissions, or alleged untrue statements or omissions, made in the Registration Statement
(or any amendment thereto), including the Rule 430B information, any preliminary prospectus, any Issuer Free Writing Prospectus
or the Prospectus (or any amendment or supplement thereto) in reliance upon and in conformity with written information furnished
to the Company by or on behalf of the Underwriters expressly for use therein, which information is described in Section 2(a)(1)
hereof.
(c)
Actions Against Parties; Notification. Each indemnified party shall give notice as
promptly as reasonably practicable to each indemnifying party of any action commenced against it in respect of which indemnity
may be sought hereunder, but failure to so notify an indemnifying party shall not relieve such indemnifying party from any liability
hereunder to the extent it is not materially prejudiced as a result thereof and in any event shall not relieve it from any liability
which it may have otherwise than on account of this indemnity agreement. In the case of parties indemnified pursuant to Section
7(a) above, counsel to the indemnified parties shall be selected by the Underwriters, and, in the case of parties indemnified
pursuant to Section 7(b) above, counsel to the indemnified parties shall be selected by the Company. An indemnifying party
may participate at its own expense in the defense of any such action; provided, however, that counsel to the indemnifying
party shall not (except with the consent of the indemnified party) also be counsel to the indemnified party. In no event shall
the indemnifying parties be liable for fees and expenses of more than one counsel (in addition to any local counsel) separate from
their own counsel for all indemnified parties in connection with any one action or separate but similar or related actions in the
same jurisdiction arising out of the same general allegations or circumstances. No indemnifying party shall, without the prior
written consent of the indemnified parties, settle or compromise or consent to the entry of any judgment with respect to any litigation,
or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever in respect
of which indemnification or contribution could be sought under this Section 7 or Section 8 hereof (whether or not
the indemnified parties are actual or potential parties thereto), unless such settlement, compromise or consent (i) includes an
unconditional release of each indemnified party from all liability arising out of such litigation, investigation, proceeding or
claim and (ii) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of
any indemnified party.
(d)
Settlement without Consent if Failure to Reimburse. If at any time an indemnified
party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of counsel, such indemnifying
party agrees that it shall be liable for any settlement of the nature contemplated by Section 7(a)(ii) effected without
its written consent if (i) such settlement is entered into more than 60 days after receipt by such indemnifying party of the aforesaid
request, (ii) such indemnifying party shall have received notice of the terms of such settlement at least 30 days prior to such
settlement being entered into and (iii) such indemnifying party shall not have reimbursed such indemnified party for the fees and
expenses of counsel in accordance with such request prior to the date of such settlement.
Section
8. Contribution.
(a)
If the indemnification provided for in Section 8 hereof is for any reason unavailable
to or insufficient to hold harmless an indemnified party in respect of any losses, liabilities, claims, damages or expenses referred
to therein, then each indemnifying party shall contribute to the aggregate amount of such losses, liabilities, claims, damages
and expenses incurred by such indemnified party, as incurred, (i) in such proportion as is appropriate to reflect the relative
benefits received by the Company, on the one hand, and the Underwriters, on the other hand, from the offering of the Securities
pursuant to this Agreement or (ii) if the allocation provided by clause (i) is not permitted by applicable law, in such proportion
as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also the relative fault of the
Company, on the one hand, and of the Underwriters, on the other hand, in connection with the statements or omissions, which resulted
in such losses, liabilities, claims, damages or expenses, as well as any other relevant equitable considerations.
(b)
The relative benefits received by the Company, on the one hand, and the Underwriters, on
the other hand, in connection with the offering of the Securities pursuant to this Agreement shall be deemed to be in the same
respective proportions as the total net proceeds from the sale of the Securities pursuant to this Agreement (before deducting expenses)
received by the Company and the total net proceeds received by the Underwriters from the resale of the Securities (after deducting
the purchase price paid by the Underwriters to the Company for the Securities).
(c)
The relative fault of the Company, on the one hand, and the Underwriters, on the other hand,
shall be determined by reference to, among other things, whether any such untrue or alleged untrue statement of a material fact
or omission or alleged omission to state a material fact relates to information supplied by the Company or by the Underwriters
and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or
omission.
(d)
The Company and the Underwriters agree that it would not be just and equitable if contribution
pursuant to this Section 8 were determined by pro rata allocation (even if the Underwriters were treated as one entity for
such purpose) or by any other method of allocation which does not take account of the equitable considerations referred to above
in this Section 8. The aggregate amount of losses, liabilities, claims, damages and expenses incurred by an indemnified
party and referred to above in this Section 7 shall be deemed to include any legal or other expenses reasonably incurred
by such indemnified party in investigating, preparing or defending against any litigation, or any investigation or proceeding by
any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue or alleged untrue
statement or omission or alleged omission.
(e)
Notwithstanding the provisions of this Section 8, the Underwriters shall not be required
to contribute any amount in excess of the amount by which the total price at which the Securities underwritten by them and distributed
to the public were offered to the public exceeds the amount of any damages which the Underwriters have otherwise been required
to pay by reason of any such untrue or alleged untrue statement or omission or alleged omission.
(f)
No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of
the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.
(g)
For purposes of this Section 8, each person, if any, who controls an Underwriter
within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act and the Underwriters’ Affiliates
and selling agents shall have the same rights to contribution as the Underwriters, and each trustee of the Company, each officer
of the Company, and each person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section
20 of the Exchange Act shall have the same rights to contribution as the Company.
Section
9. Representations, Warranties and Agreements to Survive. All representations,
warranties and agreements contained in this Agreement or in certificates of officers of the Company or any of its Subsidiaries
submitted pursuant hereto, shall remain operative and in full force and effect (i) regardless of any investigation made by or
on behalf of the Underwriters or their Affiliates or selling agents, or any person controlling the Underwriters, any officers
or trustees of the Company or any person controlling the Company, and (ii) shall survive delivery of the Securities to the Underwriters.
Section
10. Termination of Agreement.
(a)
Termination. The Underwriters in their absolute discretion may terminate this Agreement,
by notice to the Company, as hereinafter specified at any time at or prior to the Closing Date (i) if there has been, since the
time of execution of this Agreement or since the respective dates as of which information is given in the Prospectus (exclusive
of any supplement thereto) or the Disclosure Package, any material adverse change in the condition, financial or otherwise, or
in the earnings, business affairs or business prospects of the Company and its Subsidiaries considered as one enterprise, whether
or not arising in the ordinary course of business, or (ii) if there has occurred any material adverse change in the financial markets
in the United States or the international financial markets, any outbreak of hostilities or escalation thereof or other calamity
or crisis or any change or development involving a prospective change in national or international political, financial or economic
conditions, in each case the effect of which is such as to make it, in the judgment of the Underwriters, impracticable or inadvisable
to proceed with the completion of the offering or to enforce contracts for the sale of the Securities as contemplated by the Disclosure
Package, or (iii) if trading in the securities of the Company has been suspended or materially limited by the Commission or the
NYSE, or (iv) if trading generally on the NYSE or in the Nasdaq Global Market has been suspended or materially limited, or minimum
or maximum prices for trading have been fixed, or maximum ranges for prices have been required, by any of said exchanges or by
order of the Commission, the FINRA or any other governmental authority, or a material disruption has occurred in commercial banking
or securities settlement or clearance services in the United States, or (iv) if a banking moratorium has been declared by either
Federal or New York authorities.
(b)
Liabilities. If this Agreement is terminated pursuant to this Section 10,
such termination shall be without liability of any party to any other party except as provided in Section 5 hereof, and
except that Sections 2, 7, 8, 9, 13, 14 and 17 shall survive such termination
and remain in full force and effect.
Section
11. Default by the Underwriters.
(a)
If any Underwriter or Underwriters shall fail at the Closing Date or an Option Closing Date
to purchase the Initial Securities or Option Securities which it is obligated to purchase under this Agreement, and if the Initial
Securities or Option Securities with respect to which such failure to purchase relates (the “Default Securities”)
do not (after giving effect to arrangements, if any, made by the Underwriters pursuant to subsection (b) below) exceed in the aggregate
10% of the number of Initial Securities or Option Securities, each non-defaulting Underwriter, acting severally and not jointly,
agrees to purchase from the Company that number of Default Securities that bears the same proportion of the total number of Default
Securities then being purchased as the number of Initial Securities set forth opposite the name of such Underwriter in Schedule
I hereto bears to the aggregate number of Initial Securities set forth opposite the names of the non-defaulting Underwriters,
subject, however, to such adjustments to eliminate fractional shares as the Underwriters in their sole discretion shall make.
(b)
In the event the aggregate number of Default Securities exceeds 10% of the number of Initial
Securities or Option Securities, as the case may be, the Underwriters may in their discretion arrange for themselves or for another
party or parties (including any non-defaulting Underwriter who so agrees) to purchase the Default Securities on the terms contained
herein. In the event that within five calendar days after such default the Underwriters do not arrange for the purchase of the
Default Securities as provided in this Section 11, this Agreement or, in the case of a default with respect to the Option
Securities, the obligations of the Underwriters to purchase and of the Company to sell such Option Securities shall thereupon terminate,
with no liability on the part of the Company with respect thereto (except in each case as provided in Sections 5, 7,
8, 9 and 10) or the Underwriters, but nothing in this Agreement shall relieve a defaulting Underwriter of
its liability, if any, to the other Underwriters and the Company for damages occasioned by its default hereunder.
(c)
In the event that any Default Securities are to be purchased by the non-defaulting Underwriters,
or are to be purchased by another party or parties as aforesaid, the Underwriters or the Company shall have the right to postpone
the Initial Closing Date or Option Closing Date, as the case may be, for a period not exceeding five business days, in order to
effect whatever changes may thereby be made necessary in the Registration Statement or the Prospectus or in any other documents
and arrangements, and the Company agrees to file promptly any amendment or supplement to the Registration Statement or the Prospectus
which, in the opinion of the Underwriters’ counsel, may thereby be made necessary or advisable. The term “Underwriter”
as used in this Agreement shall include any party substituted under this Section 11 with like effect as if it had originally
been a party to this Agreement with respect to such Initial Securities and Option Securities.
Section
12. Notices. Except as otherwise provided in this Agreement, all notices
and other communications hereunder shall be in writing and shall be deemed to have been duly given if mailed or transmitted by
any standard form of telecommunication. Notices to the Underwriters shall be directed to Wells Fargo Securities, LLC, 375 Park
Avenue, New York, New York 10152, Attention: Equity Syndicate Department, fax no. (212) 214-5918; or J.P. Morgan Securities LLC,
383 Madison Avenue, 5th Floor, New York, New York 10179, with a copy to Goodwin Procter LLP, 620 Eighth Avenue, New
York, NY 10018, Attention: Mark Schonberger, Esq.; notices to the Company shall be directed to it at Lexington Realty Trust, One
Penn Plaza, Suite 4015, New York, New York 10119, Attention: Joseph S. Bonventre, Esq., General Counsel, fax no. (212) 594-6600,
with a copy to Paul Hastings LLP, 1170 Peachtree Street NE #100, Atlanta, GA 30309, Attention: Elizabeth Noe, fax no. (404) 685-5287.
Section
13. Parties. This Agreement shall inure to the benefit of and be binding
upon the Underwriters, the Company, and their respective successors. Nothing expressed or mentioned in this Agreement is intended
or shall be construed to give any person, firm or corporation, other than the Underwriters, the Company, and their respective
successors and the controlling persons and officers, directors and trustees referred to in Section 7 and 8 hereof
and their heirs and legal representatives, any legal or equitable right, remedy or claim under or in respect of this Agreement
or any provision herein contained. This Agreement and all conditions and provisions hereof are intended to be for the sole and
exclusive benefit of the Underwriters, the Company, and their respective successors, and said controlling persons and officers,
directors and trustees and their heirs and legal representatives, and for the benefit of no other person, firm or corporation.
No purchaser of Securities from the Underwriters shall be deemed to be a successor by reason merely of such purchase.
Section
14. Governing Law and Time. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED
IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK. SPECIFIED TIMES OF DAY REFER TO NEW YORK CITY TIME. TIME IS OF THE ESSENCE
OF THIS AGREEMENT.
Section
15. Effect of Headings. The Section and Exhibit Headings herein are for convenience
only and shall not affect the construction hereof.
Section
16. Absence of Fiduciary Relationship. The Company hereby acknowledges and
agrees:
(a)
The Underwriters are acting solely as underwriters in connection with the public offering
of the Securities and no fiduciary, advisory or agency relationship between the Company, on the one hand, and each Underwriter,
on the other hand, has been or will be created in respect of any of the transactions contemplated by this Agreement, irrespective
of whether or not the Underwriters have advised or are advising the Company on other matters, and the Underwriters do not have
any obligation to the Company with respect to the transactions contemplated by this Agreement except the obligations expressly
set forth in this Agreement;
(b)
it is capable of evaluating and understanding, and understands and accepts, the terms, risks
and conditions of the transactions contemplated by this Agreement;
(c)
in connection with each transaction contemplated by this Agreement and the process leading
to such transactions, the Underwriters are and have been acting solely as principals and not as fiduciaries, advisors or agents
of the Company or LCIF or any of their respective affiliates, stockholders (or other equity holders), creditors or employees or
any other party
(d)
the Underwriters have not provided any legal, accounting, regulatory or tax advice with
respect to the transactions contemplated by this Agreement and they have consulted their own legal, accounting, regulatory and
tax advisors to the extent they have deemed appropriate;
(e)
it is aware that the Underwriters and their respective affiliates are engaged in a broad
range of transactions which may involve interests that differ from those of the Company and the Underwriters do not have any obligation
to disclose such interests and transactions to the Company by virtue of any fiduciary, advisory or agency relationship or otherwise;
and
(f)
it waives, to the fullest extent permitted by law, any claims it may have against the Underwriters
for breach of fiduciary duty or alleged breach of fiduciary duty and agrees that the Underwriters shall not have any liability
(whether direct or indirect, in contract, tort or otherwise) to it in respect of such a fiduciary duty claim or to any person asserting
a fiduciary duty claim on its behalf or in right of it or the Company or any shareholders, employees or creditors of Company.
Section
17. Trial by Jury. The Company (on its behalf and, to the extent permitted
by applicable law, on behalf of its shareholders and affiliates) and each of the Underwriters hereby irrevocably waives, to the
fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating
to this Agreement or the transactions contemplated hereby.
Section
18. Counterparts. This Agreement may be executed in any number of counterparts,
each of which shall be deemed to be an original, but all such counterparts shall together constitute one and the same Agreement.
Section
19. Partial Unenforceability. The invalidity or unenforceability of any section,
paragraph or provision of this Agreement shall not affect the validity or enforceability of any other section, paragraph or provision
hereof. If a section, paragraph or provision of this Agreement is for any reason determined to be invalid or unenforceable, there
shall be deemed to be made such minor changes (and only such minor changes) as are necessary to make it valid and enforceable.
Section
20. Recognition of the U.S. Special Resolution Regimes.
(a)
In the event that any Representative that is a Covered Entity becomes subject to a proceeding
under a U.S. Special Resolution Regime, the transfer from such Representative of this Agreement, and any interest and obligation
in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution
Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the
United States.
(b)
In the event that any Representative that is a Covered Entity or a BHC Act Affiliate of
such Representative becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement
that may be exercised against such Representative are permitted to be exercised to no greater extent than such Default Rights could
be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state
of the United States.
(c)
For purposes of this Section 20, a “BHC Act Affiliate” has the
meaning assigned to the term “affiliate” in, and shall be interpreted in accordance with, 12 U.S.C. § 1841(k).
“Covered Entity” means any of the following: (i) a “covered entity” as that term is defined
in, and interpreted in accordance with, 12 C.F.R. § 252.82(b); (ii) a “covered bank” as that term is defined
in, and interpreted in accordance with, 12 C.F.R. § 47.3(b); or (iii) a “covered FSI” as that term is defined
in, and interpreted in accordance with, 12 C.F.R. § 382.2(b). “Default Right” has the meaning assigned
to that term in, and shall be interpreted in accordance with, 12 C.F.R. §§ 252.81, 47.2 or 382.1, as applicable. “U.S.
Special Resolution Regime” means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder
and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.
[Signature Page Follows.]
If the foregoing is
in accordance with your understanding of our agreement, please sign and return to the Company a counterpart hereof, whereupon this
instrument, along with all counterparts, will become a binding agreement between the Underwriters and the Company in accordance
with its terms.
| |
Very truly yours, |
| |
|
| |
LEXINGTON REALTY TRUST |
| |
|
|
| |
By: |
/s/ Joseph S. Bonventre |
| |
Name: |
Joseph S. Bonventre |
| |
Title: |
Executive Vice President |
| CONFIRMED AND ACCEPTED, as of the |
|
| date first above written: |
|
| |
|
| J.P. MORGAN SECURITIES LLC |
|
| |
|
|
| By: |
/s/ Haley Trethaway |
|
| Name: |
Haley Trethaway |
|
| Title: |
Vice President |
|
| |
|
|
| WELLS FARGO SECURITIES, LLC |
|
| |
|
|
| By: |
/s/ Chris Flouhouse |
|
| Name: |
Chris Flouhouse |
|
| Title: |
Managing Director |
|
Signature Page – Underwriting Agreement
for Lexington Realty Trust
Schedule I
| Underwriter | |
Total Number of Initial
Securities to be
Purchased | | |
Number of Option Securities to
be Purchased if Option is Fully
Exercised | |
| J.P. Morgan Securities LLC | |
| 5,000,000 | | |
| 750,000 | |
| Wells Fargo Securities, LLC | |
| 5,000,000 | | |
| 750,000 | |
Schedule II
Issuer General Use Free Writing Prospectuses
None.
Schedule III
Oral Pricing Information that will
be conveyed to Purchasers of Common Shares in this Offering
| 1. | The number of common shares sold in the offering is 10,000,000
common shares. |
| 2. | Offering price to the public: With respect to each investor,
the price paid by such investor. |
Schedule IV
Trustees and Executive Officers Required
to Execute Lock-Up Agreements
Joseph S. Bonventre
Beth Boulerice
Patrick Carroll
James Dudley
T. Wilson Eglin
Richard S. Frary
Lawrence L. Gray
Jamie Handwerker
Lara Johnson
Claire A. Koeneman
Brendan Mullinix
Howard Roth
